Updating results

4 results

Sort: Relevance | Date

Neratinib for treating early hormone receptor-positive HER2-positive breast cancer after adjuvant trastuzumab [ID981]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 28 August 2019.

Technology appraisal guidance In consultation

Cannabidiol for adjuvant treatment of seizures associated with Lennox-Gastaut syndrome [ID1308]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 16 September 2019.

Technology appraisal guidance In consultation

Cannabidiol for adjuvant treatment of seizures associated with Dravet syndrome [ID1211]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 16 September 2019.

Technology appraisal guidance In consultation

Rucaparib for maintenance treatment of recurrent platinum-sensitive epithelial ovarian, fallopian tube and peritoneal cancer that has responded to platinum-based chemotherapy [ID1485]: appraisal consultation

We are listening to your views on this technology appraisal guidance. Comments close 27 August 2019.

Technology appraisal guidance In consultation